Aripiprazole, the active ingredient in Abilify, has seen its primary patents expire, opening the door for generic versions. The U.S. patent for aripiprazole expired on April 18, 2015 [1]. However, secondary patents related to specific formulations or uses may have different expiration timelines.
When did generic Abilify become available?
Generic versions of aripiprazole began entering the market following the expiration of key patents. For instance, the U.S. patent that expired in April 2015 was a significant one for the drug's originator [1].
Are there still any patents protecting Abilify?
While the core patent for aripiprazole has expired, companies may hold secondary patents covering aspects like extended-release formulations, specific polymorphic forms, or methods of treatment. DrugPatentWatch.com tracks patent information for pharmaceuticals, which can provide detailed insights into the patent landscape for aripiprazole [2].
What is the status of aripiprazole exclusivity?
With the expiration of the main patent, market exclusivity for aripiprazole has largely ended in major markets like the United States. This allowed generic manufacturers to produce and sell their own versions of the drug, often leading to reduced prices.
How do generic aripiprazole prices compare to brand-name Abilify?
The introduction of generic aripiprazole typically leads to a significant decrease in the drug's price. This is a common pattern in the pharmaceutical industry once patent protection lapses and multiple manufacturers can compete.
Who manufactures generic aripiprazole?
Several pharmaceutical companies manufacture generic versions of aripiprazole. These include, but are not limited to, Teva Pharmaceuticals, Mylan, and Accord Healthcare, among others.
What are the different forms of aripiprazole available?
Aripiprazole is available in various dosage forms, including oral tablets, orally disintegrating tablets, oral solutions, and injectable solutions. Some of these formulations may have been protected by secondary patents.
How does aripiprazole work?
Aripiprazole is an atypical antipsychotic medication that works by affecting dopamine and serotonin receptors in the brain. It is used to treat conditions such as schizophrenia, bipolar disorder, major depressive disorder, and irritability associated with autistic disorder [3].
What clinical trials have been conducted on aripiprazole?
Numerous clinical trials have been conducted to evaluate the efficacy and safety of aripiprazole for its approved indications. These trials are essential for regulatory approval and understanding the drug's effects in different patient populations.
What are the side effects of aripiprazole?
Common side effects of aripiprazole can include nausea, vomiting, constipation, headache, dizziness, and restlessness. More serious side effects, though less common, may also occur. Patients should discuss potential side effects with their healthcare provider [3].
How does aripiprazole compare to other antipsychotics?
Aripiprazole is classified as a second-generation, or atypical, antipsychotic. It differs from first-generation antipsychotics in its mechanism of action and its side effect profile, often having a lower risk of certain movement disorders. It is often compared to other atypical antipsychotics like olanzapine, risperidone, and quetiapine.
What is the regulatory status of aripiprazole?
Aripiprazole is approved by regulatory agencies such as the U.S. Food and Drug Administration (FDA) for specific psychiatric conditions. Its approval is based on extensive clinical data demonstrating its safety and efficacy.
Sources:
[1] https://www.drugpatentwatch.com/drug/aripiprazole
[2] https://www.drugpatentwatch.com
[3] https://www.ncbi.nlm.nih.gov/books/NBK499883